About Systemic Mastocytosis

Overview
Systemic mastocytosis is a rare blood disorder characterized by the accumulation of abnormal mast cells in various organs throughout the body. Mast cells are immune cells that play a role in allergic reactions and inflammation. In systemic mastocytosis, these mast cells build up in organs such as the bone marrow, liver, spleen, lymph nodes, and small intestines. This condition can affect people of all ages but is most commonly seen in adults. The symptoms of systemic mastocytosis can vary depending on which organs are affected but may include fatigue, skin redness and warmth, abdominal pain, diarrhea, nasal congestion, shortness of breath, low blood pressure, and severe allergic reactions. There are different subtypes of systemic mastocytosis, ranging from mild to more severe forms. The diagnosis is made based on specific criteria set by medical professionals. Treatment options aim to manage symptoms and prevent complications.
Causes and Risk Factors

Systemic mastocytosis is caused by the accumulation of mast cells in various organs throughout the body. The main cause of this condition is mutations in the KIT gene, which controls cell growth and division. These mutations result in an overactive KIT protein, leading to increased production and accumulation of mast cells. The accumulated mast cells can gather in the bone marrow, gastrointestinal tract, lymph nodes, spleen, or liver.

As for risk factors, there are both non-modifiable and modifiable factors to consider:

Non-modifiable risk factors for systemic mastocytosis cannot be changed or controlled. This includes:

  • Genetic mutation: Mutations in the KIT gene are acquired during a person's lifetime and play a role in the development of systemic mastocytosis.

Modifiable risk factors for systemic mastocytosis can be influenced or changed. These include:

  • Triggers: Certain factors may activate mast cells, including friction, minor injury, surgery, temperature changes, insect stings, some vaccines, anxiety or stress, and certain medications like opioids, aspirin, and nonsteroidal anti-inflammatory drugs.

It's important to note that while these risk factors may contribute to the development of systemic mastocytosis, they do not guarantee its occurrence. If you suspect you have this condition or have concerns about your symptoms, it's best to consult with a healthcare professional for an accurate diagnosis and appropriate treatment plan.

Symptoms

The most common early symptoms of systemic mastocytosis include:

  • Headache
  • Abdominal or stomach pain
  • Nausea or vomiting
  • Diarrhea
  • Muscle or bone pain
  • Anemia
  • Trouble sensing temperature changes
  • Flushing of the skin
  • Low blood pressure
  • Shortness of breath

As the condition progresses or reaches a higher severity, additional symptoms may occur. These can include:

  • Rash-like skin lesions
  • Intestinal malabsorption (trouble absorbing fluid and nutrients from food)
  • Peptic ulcer disease
  • Osteoporosis (bone weakening)
  • Swollen lymph nodes
  • Enlarged liver and spleen
  • Atypical growth of cells (dysplasia)
  • Reduced number of blood cells (cytopenia)
  • Bone degeneration (osteolysis)
  • Fluid collection in the abdomen (ascites)
  • Severe allergic reactions (anaphylaxis)

It is important to note that symptoms can vary depending on the individual and the subtype of systemic mastocytosis. If you experience any of these symptoms, it is recommended to consult with a healthcare professional for an accurate diagnosis and appropriate management.

Diagnosis

To diagnose systemic mastocytosis, doctors commonly perform the following examinations, tests, and procedures:

  • Physical examination: The healthcare provider will look for physical signs such as unusual skin abnormalities, swelling, or tenderness in areas like the abdomen, which may indicate organ enlargement. They may also check for symptoms like rashes or flushing and ask about any history of allergic reactions or other related symptoms. This helps identify potential signs of the condition and guide further testing.
  • Blood tests: A complete blood count (CBC) can help identify any abnormalities in blood cell counts. Elevated levels of tryptase, a chemical released by mast cells, can also indicate systemic mastocytosis.

To assess the extent or type of systemic mastocytosis, additional examinations, tests, and procedures may be performed:

  • Bone marrow biopsy: A sample of bone marrow tissue is taken using a long needle to check for irregularities in the bone marrow. This procedure helps identify if mast cell overproduction has spread beyond the skin.
  • Imaging tests: Ultrasounds and dual-energy X-ray absorptiometry (DEXA) scans can provide detailed images of internal organs and assess bone density. These tests help determine if there are any abnormalities in specific organs.
  • Genetic testing: Genetic tests use samples of blood or other tissues to identify changes in genes or chromosomes that may be associated with systemic mastocytosis.

It's important to consult with your healthcare provider about which specific examinations, tests, and procedures are appropriate for your individual situation.

Treatment Options

The goals of treatment for systemic mastocytosis are to manage symptoms, prevent mast cell overactivity, and improve quality of life. The following treatments may be recommended:

  • Antihistamines: These medications help to reduce the effects of histamine released by mast cells, which can alleviate skin and gastrointestinal symptoms.
  • Mast cell stabilizers (such as cromolyn sodium): These medications work by preventing the release of histamine from mast cells, helping to prevent allergic reactions and reduce symptoms.
  • Proton pump inhibitors: These medications can be used to manage gastrointestinal symptoms by reducing stomach acid production.
  • Oral steroids: Steroids may be prescribed to improve nutrient uptake and reduce inflammation in the skin and gut.
  • Steroid cream: Topical steroids can help relieve skin inflammation associated with mastocytosis.
  • Epinephrine: This medication is used for severe allergic reactions, such as anaphylaxis.
  • Bisphosphonates: These medications can help prevent bone loss in individuals with systemic mastocytosis.
  • Cladribine: This chemotherapeutic agent targets immune cells, including mast cells, to slow their growth and spread. It is often used for people with advanced systemic mastocytosis.
  • Midostaurin: This medication works by blocking the activity of mast cell receptors, inhibiting the growth of mast cells and the release of histamine. It is approved for the treatment of aggressive forms of systemic mastocytosis.

It's important to note that treatment plans may vary depending on the type and severity of systemic mastocytosis. Consult with a healthcare professional for personalized advice.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.